A comparison of cycle control, efficacy, and side effects among healthy Thai women between two low-dose oral contraceptives containing 20 microg ethinylestradio1/75 microg gestodene (Meliane) and 30 microg ethinylestradio1/75 microg gestodene (Gynera).

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Contraception

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12499032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical trial of a monophasic estroprogestin oral formulation containing 20 micrograms ethinyl estradiol and 75 micrograms gestodene.

  2001cited by this paper
• Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women.

  2000cited by this paper
• An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.

  1999cited by this paper
• Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.

  1999cited by this paper
• A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 micrograms ethinylestradiol and either 150 micrograms desogestrel or 75 micrograms gestodene.

  1998cited by this paper
• Menstrual problems and side effects associated with long-term TCu 380A IUD use in perimenopausal women.

  1998cited by this paper
• A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle control and tolerance.

  1995cited by this paper

• [Hypertension and contraception].

  2019cites this paper
• Combination contraceptives: effects on weight.

  2014cites this paper
• 20 µg versus >20 µg estrogen combined oral contraceptives for contraception.

  2013cites this paper
• Combination contraceptives: effects on weight.

  2011cites this paper
• 20 µg versus >20 µg estrogen combined oral contraceptives for contraception.

  2011cites this paper
• Synchronic release of two hormonal contraceptives for about one month from the PLGA microspheres: in vitro and in vivo studies.

  2008cites this paper
• Combination contraceptives: effects on weight.

  2008cites this paper
• 20 microg versus >20 microg estrogen combined oral contraceptives for contraception.

  2008cites this paper
• Combination contraceptives: effects on weight.

  2006cites this paper
• 20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception.

  2005cites this paper
• Twenty micrograms vs. >20 microg estrogen oral contraceptives for contraception: systematic review of randomized controlled trials.

  2005cites this paper
• Clinical and metabolic aspects of the continuous use of a contraceptive association of ethinyl estradiol (30 microg) and gestodene (75 microg).

  2004cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2004cites this paper